ES2107198T3 - Uso de lectinas para el tratamiento de enfermedades cutaneas. - Google Patents

Uso de lectinas para el tratamiento de enfermedades cutaneas.

Info

Publication number
ES2107198T3
ES2107198T3 ES94910257T ES94910257T ES2107198T3 ES 2107198 T3 ES2107198 T3 ES 2107198T3 ES 94910257 T ES94910257 T ES 94910257T ES 94910257 T ES94910257 T ES 94910257T ES 2107198 T3 ES2107198 T3 ES 2107198T3
Authority
ES
Spain
Prior art keywords
lectines
treatment
skin diseases
champus
keratose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94910257T
Other languages
English (en)
Inventor
Jonathan Michael Spring Rhodes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Application granted granted Critical
Publication of ES2107198T3 publication Critical patent/ES2107198T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

CIERTAS LECTINAS, PRINCIPALMENTE LAS QUE SE PUEDEN LIGAR CON ANTIGENO TF SIALILATADO, ESPECIALMENTE LA LECTINA DE HONGO DE AGARICUS BISPORUS, SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES DE LA PIEL, COMO PSORIASIS Y QUERATOSAS BENIGNAS. SE PUEDEN FORMULAR COMO CREMAS, UNGUENTOS, LOCIONES COSMETICAS O CHAMPUS, POR EJEMPLO.
ES94910257T 1992-09-19 1993-09-10 Uso de lectinas para el tratamiento de enfermedades cutaneas. Expired - Lifetime ES2107198T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219905A GB9219905D0 (en) 1992-09-19 1992-09-19 Lectins

Publications (1)

Publication Number Publication Date
ES2107198T3 true ES2107198T3 (es) 1997-11-16

Family

ID=10722223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94910257T Expired - Lifetime ES2107198T3 (es) 1992-09-19 1993-09-10 Uso de lectinas para el tratamiento de enfermedades cutaneas.

Country Status (9)

Country Link
US (1) US5607679A (es)
EP (1) EP0661995B1 (es)
AT (1) ATE156364T1 (es)
AU (1) AU670628B2 (es)
CA (1) CA2144050A1 (es)
DE (1) DE69312948T2 (es)
ES (1) ES2107198T3 (es)
GB (2) GB9219905D0 (es)
WO (1) WO1994006462A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608145D0 (en) * 1996-04-19 1996-06-26 British Tech Group Wound healing
US6200569B1 (en) 1997-11-05 2001-03-13 Tang-An Medical Co., Ltd. Composition and method for increasing insulin activity
US6093745A (en) * 1997-11-25 2000-07-25 Psorx, L.L.C. Methods and composition for treating skin proliferative diseases
US6861077B1 (en) 2000-03-17 2005-03-01 L'oreal S.A. Use of plant extracts in a cosmetic composition to protect keratinous fibers
US6645502B2 (en) 2001-09-17 2003-11-11 Revlon Consumer Products Corporation Anhydrous cosmetic compositions containing mushroom extract
US6923494B2 (en) * 2002-08-23 2005-08-02 General Electric Company Pedestrian energy absorber for automotive vehicles
US20040126449A1 (en) * 2002-12-30 2004-07-01 Gopa Majmudar Topical composition and methods for treatment of aged or environmentally damaged skin
GB0819883D0 (en) 2008-10-29 2008-12-03 Azyme Res As Product and uses
PT3418296T (pt) 2009-02-18 2024-10-04 Unichem Lab Ltd Lectinas recombinantes de ligação a células cancerígenas com atividade antitumoral e método de preparação
BR112021004792A2 (pt) * 2018-09-16 2021-08-03 Unichem Laboratories Ltd proteína para tratamento de doenças inflamatórias

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217341A (en) * 1977-12-07 1980-08-12 The University of Louisville Composition and method for inhibiting the adherence of dental plaque-producing bacteria to smooth surfaces
DE3067048D1 (en) * 1979-12-03 1984-04-19 Kitasato Inst A process for preparing substances having interferon inducing activity and interferon inducers
JPS6013004B2 (ja) * 1980-08-06 1985-04-04 北里研究所（社団法人） インタ−フエロン誘起剤の製法
US4742046A (en) * 1984-08-03 1988-05-03 Medisearch S.A. Methods and compositions for inhibiting the infectious activity of viruses
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
JPS61205218A (ja) * 1985-03-08 1986-09-11 Ajinomoto Co Inc 抗腫瘍剤
JPH0825890B2 (ja) * 1987-06-18 1996-03-13 呉羽化学工業株式会社 抗ウイルス剤

Also Published As

Publication number Publication date
US5607679A (en) 1997-03-04
GB2270626B (en) 1996-03-13
WO1994006462A1 (en) 1994-03-31
EP0661995A1 (en) 1995-07-12
AU670628B2 (en) 1996-07-25
GB9318807D0 (en) 1993-10-27
DE69312948D1 (de) 1997-09-11
EP0661995B1 (en) 1997-08-06
DE69312948T2 (de) 1998-01-02
CA2144050A1 (en) 1994-03-31
ATE156364T1 (de) 1997-08-15
GB2270626A (en) 1994-03-23
GB9219905D0 (en) 1992-11-04
AU4978393A (en) 1994-04-12

Similar Documents

Publication Publication Date Title
BR9306768A (pt) Artigo e estrutura absorventes extensíveis
ES2095017T3 (es) Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.
CR7786A (es) Anticuerpos neutralizantes contra gdf-8 y el uso de los mismos
ES2090631T3 (es) Utilizacion de esfingolipidos, en la preparacion de una composicion cosmetica o dermofarmaceutica que protege la piel y los cabellos contra los efectos nocivos de la polucion atmosferica.
ATE240092T1 (de) Mittel gegen hyperreaktive und hypoaktive, defizitäre hautzustände sowie manifeste dermatiden
CO4340688A1 (es) Derivados de quinazolina y procedimientos de uso de los mismos, como agentes contra el cancer, en los mamiferos.
ES2094033T3 (es) Composicion cosmetica y/o dermatologica que contiene derivados de acido salicilico y procedimiento de solubilizacion de estos derivados.
MX9301047A (es) Recubrimiento para la reduccion del arrastre del tejido.
BR0208076A (pt) Células t cd4*cd25* reguladoras de sangue humano
CO4130178A1 (es) Composicion para el cuidado personal en forma de gel, que tiene propiedades viscoelasticas
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
MX9504625A (es) Composicion de lipidos para productos cosmeticos.
ES2061419T1 (es) Derivados de benzofurano y su uso como estabilizadores contra las radiaciones uv.
ES2065647T3 (es) Empleo cosmetico de una composicion que tiene una actividad antieritematosa.
BR9205076A (pt) Composicao cosmetica de oleogel adequada para aplicacao topica a superficie da pele humana processo para preparar uma composicao cosmetica de oleogel adequada para aplicacao topica a superficie a pele humana,e,processo de obtencao dd uma camada oclusiva sobre a pele humana,cabelos ou unhas
ES2184971T3 (es) Utilizacion de polidimetilsiloxanos de grupos glucosidos como agentes hidratantes en una composicion cosmetica o dermatologica.
ES2106624T3 (es) Composicion que contiene un precursor de dihidroacetona.
ES2064119T3 (es) Nuevos derivados de aminobenzosultam como inhibidores de la lipoxigenasa.
EP1091924A4 (en) NOVEL RETINOIDS AND ASSOCIATED USES
ES2073125T3 (es) Uso de compuestos de vitamina d para la produccion de una composicion cosmetica y su uso para mejorar las condiciones de la piel.
AR003758A1 (es) Composicion cosmetica para uso topico, en particular para la fotoproteccion de la piel y/o de los cabellos, procedimiento de tratamiento cosmetico que laemplea, utilizacion de un acilaminoacido en una composicion que contiene pigmentos de oxido de titanio y procedimiento para reducir el fotoazulamiento
DE69312948D1 (de) Verwendung von lectinen für die behandlung von krankheiten
PA8506201A1 (es) Quimioterapia de combinacion (combination chemotherapy)
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661995

Country of ref document: ES